It’s been a whirlwind year for the A4M blog! We’ve published nearly 50 articles on everything from microbiome transplants and other breakthrough longevity discoveries to pediatric mental health and promising interventions. Now, as we wrap up an incredible year for A4M, we wanted to take a moment to look back at the most popular blog articles of 2022.
We hope this review serves as a reminder of all the exceptional work done in our industry and community this year and serves as inspiration as we continue working toward a healthier future for all.
Here are the top 10 most-read articles of the year:
Now that we’ve seen the best of the year, it’s time to look ahead. We’re looking forward to sharing the industry’s top news and research developments with you in the coming year, and we hope you’ll continue to join us.
Last weekend, A4M hosted the largest anti-aging medicine event ever, gathering over 5,500 guests, 120 globally renowned speakers and educators, and 400 market-shaping companies. Delivering four full days of cutting-edge science, the latest research, and meaningful, practical education, LongevityFest 2022 marked a pivotal point in A4M’s history and that of the specialty itself.
The conference was packed with noteworthy moments: from a keynote address by the celebrated innovator Peter Diamandis, MD, to the launch of new products from industry leaders like Precision Analytical and Quicksilver Scientific. But most exciting was seeing so many people coming together to celebrate this growing field and its future.
While there were too many unforgettable happenings to list, this blog highlights some of the most noteworthy educational takeaways presented by our star-studded panel of experts at LongevityFest 2022.
Although the human lifespan has increased over recent decades, the human health-span has been unable to keep pace. While we are living longer due to scientific advancements, the number of years we spend without age-related diseases has not increased proportionately.
Lifestyle interventions often recommended too late in life tend not to be sufficient to prevent, halt, or reverse age-related decline. Research scientists are increasingly focusing on potential pharmaceutical interventions to combat the negative aspects of aging. One pathway of exploration aims to repurpose existing medications for geroprotection and is proving remarkably successful in early trials.